Europe Self Monitoring Blood Glucose Devices Market Size & Outlook
Related Markets
Europe self monitoring blood glucose devices market highlights
- The Europe self monitoring blood glucose devices market generated a revenue of USD 1,830.0 million in 2022.
- The market is expected to grow at a CAGR of 7.7% from 2023 to 2030.
- In terms of segment, testing strips was the largest revenue generating product in 2022.
- Blood Glucose Meter is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 1,830.0 million |
| Market revenue in 2030 | USD 3,306.8 million |
| Growth rate | 7.7% (CAGR from 2022 to 2030) |
| Largest segment | Testing strips |
| Fastest growing segment | Blood Glucose Meter |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Glucose Meter, Testing Strips |
| Key market players worldwide | Thermo Fisher Scientific Inc, Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, PHC Holdings Corp, DexCom Inc, Sanofi SA, Novo Nordisk A/S ADR, Insulet Corp, Ypsomed Holding AG, GlySens |
Other key industry trends
- In terms of revenue, Europe region accounted for 31.9% of the global self monitoring blood glucose devices market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,422.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Self Monitoring Blood Glucose Devices Market Scope
Self Monitoring Blood Glucose Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GlySens | View profile | 51-100 | San Diego, California, United States, North America | http://www.glysens.com |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| DexCom Inc | View profile | 9600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | https://www.dexcom.com |
| PHC Holdings Corp | View profile | 11897 | 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8433 | https://www.phchd.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Insulet Corp | View profile | 3000 | 100 Nagog Park, Acton, MA, United States, 01720 | https://www.insulet.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Europe self monitoring blood glucose devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to self monitoring blood glucose devices market will help companies and investors design strategic landscapes.
Testing strips was the largest segment with a revenue share of 58.35% in 2022. Horizon Databook has segmented the Europe self monitoring blood glucose devices market based on blood glucose meter, testing strips covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Self Monitoring Blood Glucose Devices Product Outlook (Revenue, USD Million, 2018-2030)
- Transmitter & Receiver
- End User
- Specialty Facilities
- Research And Manufacturing
- Hospital
- Home Care
- End User
- Testing Strips
- End Use
- Hospital
- Home Care
- Research And Manufacturing
- Specialty Facilities
- End Use
- Sensors
- End User
- Hospital
- Research And Manufacturing
- Specialty Facilities
- Home Care
- End User
- Insulin Pumps
- End User
- Research And Manufacturing
- Hospital
- Specialty Facilities
- Home Care
- End User
- Blood Glucose Meter
- End Use
- Hospital
- Specialty Facilities
- Home Care
- Research And Manufacturing
- End Use
- Lancets
- End Use
- Home Care
- Research And Manufacturing
- Specialty Facilities
- Hospital
- End Use
- Transmitter & Receiver
Reasons to subscribe to Europe self monitoring blood glucose devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe self monitoring blood glucose devices market databook
-
Our clientele includes a mix of self monitoring blood glucose devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe self monitoring blood glucose devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe self monitoring blood glucose devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe self monitoring blood glucose devices market size, by country, 2018-2030 (US$M)
Europe Self Monitoring Blood Glucose Devices Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
